David Wilton Purchases 2,500 Shares of CVS Group (LON:CVSG) Stock

Key Points

  • Insider purchase: David Wilton bought 2,500 shares of CVS Group on December 2 at an average price of GBX 1,219 per share, a transaction valued at £30,475.
  • Analyst sentiment: Four analysts rate the stock a Buy and one a Hold, giving a consensus "Moderate Buy" and an average target price of GBX 1,724 versus the recent opening price around GBX 1,204.
  • Key financials and price action: CVS Group is down ~2.4% recently, has a PE of 16.36, market cap £862.02m and a relatively high debt-to-equity ratio of 110.52, indicating notable leverage.

CVS Group plc (LON:CVSG - Get Free Report) insider David Wilton bought 2,500 shares of CVS Group stock in a transaction dated Tuesday, December 2nd. The shares were acquired at an average price of GBX 1,219 per share, with a total value of £30,475.

CVS Group Stock Down 2.4%

CVSG opened at GBX 1,204 on Thursday. The stock's fifty day simple moving average is GBX 1,265.17 and its 200 day simple moving average is GBX 1,248.86. CVS Group plc has a 1-year low of GBX 800 and a 1-year high of GBX 1,648. The stock has a market cap of £862.02 million, a PE ratio of 16.36, a price-to-earnings-growth ratio of 1.77 and a beta of 1.02. The company has a current ratio of 1.09, a quick ratio of 0.90 and a debt-to-equity ratio of 110.52.

CVS Group (LON:CVSG - Get Free Report) last released its quarterly earnings data on Tuesday, October 7th. The company reported GBX 80.10 EPS for the quarter. CVS Group had a net margin of 3.20% and a return on equity of 7.86%. As a group, research analysts expect that CVS Group plc will post 93.9393939 earnings per share for the current year.

Analyst Upgrades and Downgrades




CVSG has been the subject of several research analyst reports. Berenberg Bank reaffirmed a "buy" rating and set a GBX 2,000 target price on shares of CVS Group in a report on Tuesday, November 18th. Royal Bank Of Canada boosted their price objective on CVS Group from GBX 1,500 to GBX 1,900 and gave the stock an "outperform" rating in a report on Tuesday, October 21st. Jefferies Financial Group upped their target price on CVS Group from GBX 1,250 to GBX 1,420 and gave the company a "hold" rating in a research report on Wednesday, October 22nd. Deutsche Bank Aktiengesellschaft lifted their price target on CVS Group from GBX 1,500 to GBX 1,700 and gave the stock a "buy" rating in a report on Tuesday, October 21st. Finally, Peel Hunt reaffirmed a "buy" rating and issued a GBX 1,600 price objective on shares of CVS Group in a report on Tuesday, November 18th. Four equities research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus target price of GBX 1,724.

Get Our Latest Report on CVSG

About CVS Group

(Get Free Report)

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.

See Also

This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].

Insider Buying or Selling at CVS Group?
Sign-up to receive InsiderTrades.com's daily insider buying and selling report for CVS Group and related companies.
From Our Partners
Free Insider Buying and Selling Newsletter
Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report.
From Our Partners

Most Read This Month

Recent Articles